Jingjing Xiao

LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms’ tumor by regulating the miR-514a-3p/MELK axis

Huajian Gu, J. Du, Jiafei Yang, 2022, Anti-cancer drugs.

A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma

Chuan Xiao, Huajian Gu, Tao Liu, 2022, Cells.

Association between basal platelet count and all-cause mortality in critically ill patients with acute respiratory failure: a secondary analysis from the eICU collaborative research database.

Chuan Xiao, Qing Li, Zuoan Qin, 2021, American journal of translational research.

The Efficacy and Safety of Early Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials

Chuan Xiao, Qing Li, Shuwen Li, 2022, Frontiers in Medicine.

Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma

Chuan Xiao, Huajian Gu, S. Zuo, 2021, Frontiers in Molecular Biosciences.

miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS.

Y. Liu, Chuan Xiao, Qing Li, 2023, International immunopharmacology.

Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs

Huajian Gu, Jingjing Xiao, Yingquan Zhuo, 2023, Open life sciences.